Free Trial

Evogene (EVGN) SEC Filings & 10K Form

Evogene logo
$1.30 +0.05 (+3.57%)
Closing price 03:59 PM Eastern
Extended Trading
$1.32 +0.01 (+0.77%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Evogene SEC Filings

DateFilerForm TypeView
09/30/2025
6:16 AM
Evogene (Filer)
Form POS AM
09/30/2025
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2025
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2025
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/18/2025
3:01 PM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2025
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2025
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/21/2025
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2025
11:15 PM
Evogene (Filer)
Form EFFECT
03/28/2025
5:03 AM
Evogene (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/28/2025
5:09 AM
Evogene (Filer)
Form POS AM
03/27/2025
4:29 PM
Evogene (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/06/2025
6:20 AM
Evogene (Filer)
Form 424B3
03/06/2025
6:00 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
6:15 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
3:00 PM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
3:01 PM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/27/2024
3:05 PM
Evogene (Filer)
Form 424B3
11/27/2024
3:00 PM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2024
6:35 AM
Evogene (Filer)
Form 424B3
11/21/2024
6:30 AM
Evogene (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EVGN) was last updated on 10/21/2025 by MarketBeat.com Staff
From Our Partners